Viewing Study NCT03173950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2026-01-24 @ 11:49 PM
Study NCT ID: NCT03173950
Status: COMPLETED
Last Update Posted: 2025-06-29
First Post: 2017-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Medulloblastoma View
None Ependymoma View
None Pineal Region Tumors View
None Choroid Plexus Tumors View
None Atypical/Malignant Meningioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Anti-PD-1 Antibody View
None Brain Tumors View
None MDASI-BT View
None Spinal Cord Tumors View